Pharmaceutical industry professional with 20+ years' experience spanning all stages of both developing and increasing access to medicines, from target identification and validation, pre-clinical pharmacology, Phase 1 and PoC design, all the way through to product lifecycle management. Innovation expert for high value assets, leading pre-clinical and clinical studies to continually increase asset value, asset differentiation and asset positioning in near and long term portfolios.Deep understanding of life cycle management, claims development and world class research to support medical marketing initiatives.Extensive experience in project and portfolio management, project prioritization, planning and execution of intellectual property strategy, operational oversight (budget and resource management) and due diligence of in-licensing and acquisition opportunities.Drive and professionalism to lead in highly matrixed organizations across multiple geographies and time zones, expert in initiating, developing and managing external relationships, such as global thought leaders and consultants.Specialties: Scientific and technical expertise in the areas of translational medicine, inflammation, immunology, respiratory medicine, pain management, in vitro and clinical pharmacology, molecular biology, signal transduction, cell proliferation and differentiation, in both small molecule and biologic molecule development.